Boliden AB (publ) (FRA:BWJ)

Intra-Cellular Therapies Revenue

Boliden AB had revenue of 22.29B SEK in the quarter ending June 30, 2025, a decrease of -2.04%. This brings the company's revenue in the last twelve months to 91.38B, up 12.29% year-over-year. In the year 2024, Boliden AB had annual revenue of 89.21B with 13.56% growth.

• Revenue (ttm): 91.38B SEK
• Revenue Growth: +12.29%
• P/S Ratio: 0.93
• Revenue / Employee: 15.25M SEK
• Employees: 5,993
• Market Cap: 7.57B USD

Revenue Chart

* This company reports financials in SEK.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	89.21B	10.65B	13.56%
Dec 31, 2023	78.55B	-7.88B	-9.12%
Dec 31, 2022	86.44B	17.80B	25.94%
Dec 31, 2021	68.64B	12.32B	21.87%
Dec 31, 2020	56.32B	6.39B	12.79%